PR NEWSWIRE

Previous Stories

Octopus Deploy reimagines how Config as Code should be done

Mar 30 2022 - PR NewsWire

Octopus Deploy launches Config as Code that combines the power of Git with a developer-friendly interface to streamline the deployment…


MedTech Baymatob completes capital raise to advance life-saving labor monitoring device

Mar 30 2022 - PR NewsWire

SYDNEY, March 29, 2022 /PRNewswire/ — Medical device company Baymatob has completed a placement of A$4.215 million, with proceeds used…


Australian research shows that the right use of AI can significantly reduce gender bias in job interviews

Mar 29 2022 - PR NewsWire

MELBOURNE, Australia, March 29, 2022 /PRNewswire/ — PredictiveHire is pleased to announce its R&D arm, Phai Labs, will be presenting new…


New Video Series “PSMA PET/CT TODAY” Discusses the Future of Prostate Cancer Care with Leading Experts

Mar 29 2022 - PR NewsWire

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the launch…


Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment

Mar 29 2022 - PR NewsWire

MELBOURNE, Australia and INDIANAPOLIS, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United…


World-first: HB11 Energy demonstrates nuclear fusion using a laser

Mar 29 2022 - PR NewsWire

SYDNEY, March 29, 2022 /PRNewswire/ — Australia’s first fusion energy company HB11 Energy has demonstrated a world-first ‘material’ number of…


Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®

Mar 29 2022 - PR NewsWire

MELBOURNE, Australia and LIÈGE, Belgium, March 29, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it…


ASC Technologies and ADDCOM enter Alliance

Mar 29 2022 - PR NewsWire

Recording & analytics for the public and financial sector in Australia and New Zealand HÖSBACH, Germany, March 29, 2022 /PRNewswire/…


Clarity’s US-based Cu-64 SAR-bisPSMA trial in prostate cancer opens for recruitment

Mar 29 2022 - PR NewsWire

SYDNEY, March 28, 2022 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the…


YuppTV Bags Broadcasting Rights for TATA IPL 2022

Mar 28 2022 - PR NewsWire

One of the World`s largest online content streaming platforms, YuppTV received broadcasting rights of Tata IPL 2022 in 114 countries…


Analyse The Market From A Different Angle